EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

A novel homozygous intronic variant in CDT1 that alters splicing causes Meier–Gorlin syndrome, and a review of published mutations and growth hormone treatments

Qing Li, Yichi Wu, Fucheng Meng, Zhuxi Li, Di Zhan, Xiaoping Luo

Orphanet Journal of Rare Diseases · 2024

DOI: 10.1186/s13023-024-03430-4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Orphanet Journal of Rare Diseases, 2024. Verfasst von Qing Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Congenital Microtia, Growth Disorders, Human Growth Hormone. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Meier–Gorlin syndrome (MGORS) is a rare autosomal inherited form of primordial dwarfism. Pathogenic variants in 13 genes involved in DNA replication initiation have been identified in this disease, but homozygous intronic variants have never been reported. Additionally, whether growth hormone (GH) treatment can increase the height of children with MGORS is unclear.

Methods

The medical history data of a young girl were collected and reviewed. Whole-exome sequencing (WES) and bioinformatic analysis were performed to identify any variants and predict their pathogenicity. Minigene constructs were generated and transfected into HEK-293T cells for in vitro splicing assays. The literature was reviewed to explore the mutational spectrum and efficacy of GH treatment for this disease.

Results

A girl with microtia, hypoplastic patellae, and severe growth retardation carried a novel homozygous intronic variant (NM_030928.4: exon 3: c.352–30 A > C) in CDT1 . The variant was predicted to break a branch point and alter splicing, and the minigene assay confirmed abnormal splicing with exon 3 skipping. The patient was treated with GH for 5 years, with an increase in growth velocity from 4.0 cm/year to an average of 6.2 cm/year. A literature review revealed that the most common variant type and inheritance state were missense and compound heterozygous, respectively. Additionally, the vast majority of children with MGORS treated with GH had normal insulin-like growth factor 1 (IGF-1) levels, and half of them responded positively to GH therapy.

Conclusions

We reported a novel pathogenic homozygous intronic variant (c.352–30 A > C) of CDT1 in a girl with MGORS, and this mutation extended the genetic spectrum of the disease. GH therapy may be beneficial for height outcomes in children with MGORS with normal IGF-1 levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsCongenital MicrotiaGrowth DisordersHuman Growth HormoneMicrognathismChildFemaleHumansExome SequencingHomozygoteIntronsMutationRNA SplicingPatella

Stichwörter der Autor:innen

CDT1Growth hormone treatmentIntronic mutationMeier–Gorlin syndromeShort stature

Substanzen

CDT1 protein, humanCell Cycle ProteinsHuman Growth Hormone

Autor:innen und Institutionen

  • Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. xpluo@tjh.tjmu.edu.cn.
  • Hubei Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Wuhan, China. xpluo@tjh.tjmu.edu.cn.

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Li, Q., Wu, Y., Meng, F., Li, Z., Zhan, D., & Luo, X. (2024). A novel homozygous intronic variant in CDT1 that alters splicing causes Meier–Gorlin syndrome, and a review of published mutations and growth hormone treatments. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-024-03430-4

Vancouver

Li Q, Wu Y, Meng F, Li Z, Zhan D, Luo X. A novel homozygous intronic variant in CDT1 that alters splicing causes Meier–Gorlin syndrome, and a review of published mutations and growth hormone treatments. Orphanet Journal of Rare Diseases. 2024. doi:10.1186/s13023-024-03430-4

BibTeX
@article{Li2024,
  author = {Li, Qing and Wu, Yichi and Meng, Fucheng and Li, Zhuxi and Zhan, Di and Luo, Xiaoping},
  title = {A novel homozygous intronic variant in CDT1 that alters splicing causes Meier–Gorlin syndrome, and a review of published mutations and growth hormone treatments},
  journal = {Orphanet Journal of Rare Diseases},
  year = {2024},
  doi = {10.1186/s13023-024-03430-4}
}
Kostenlos starten →